Healthcare provider profile · identity verified

Ruth Blash, MD

Internal Medicine · FISHKILL, NY · NPI 1295849545

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	473	150
Levothyroxine Sodium	Levothyroxine Sodium	268	75
Amlodipine Besylate	Amlodipine Besylate	253	81
Lisinopril	Lisinopril	231	66
Omeprazole	Omeprazole	219	68
Losartan Potassium	Losartan Potassium	206	66
Rosuvastatin Calcium	Rosuvastatin Calcium	206	60
Metformin Hcl	Metformin Hcl	193	53
Zolpidem Tartrate	Zolpidem Tartrate	162	26
Metoprolol Succinate	Metoprolol Succinate	159	52
Simvastatin	Simvastatin	134	40
Gabapentin	Gabapentin	132	44
Alprazolam	Alprazolam	129	46
Tamsulosin Hcl	Tamsulosin Hcl	125	41
Pantoprazole Sodium	Pantoprazole Sodium	124	39
Hydrochlorothiazide	Hydrochlorothiazide	122	38
Metformin Hcl Er	Metformin Hcl	108	39
Tizanidine Hcl	Tizanidine Hcl	86	26
Carvedilol	Carvedilol	85	23
Metoprolol Tartrate	Metoprolol Tartrate	78	25
Atenolol	Atenolol	75	25
Duloxetine Hcl	Duloxetine Hcl	75	26
Eliquis	Apixaban	70	27
Albuterol Sulfate Hfa	Albuterol Sulfate	68	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	21
Finasteride	Finasteride	63	18
Escitalopram Oxalate	Escitalopram Oxalate	61	23
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	59	24
Glimepiride	Glimepiride	57	15
Famotidine	Famotidine	56	24
Sertraline Hcl	Sertraline Hcl	54	15
Furosemide	Furosemide	52	21
Pravastatin Sodium	Pravastatin Sodium	51	13
Synthroid	Levothyroxine Sodium	51	14
Valsartan	Valsartan	48	19
Clopidogrel	Clopidogrel Bisulfate	46	14
Tramadol Hcl	Tramadol Hcl	46	14
Trazodone Hcl	Trazodone Hcl	46	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	suppressed
Oxycodone Hcl	Oxycodone Hcl	45	suppressed
Allopurinol	Allopurinol	44	15
Buspirone Hcl	Buspirone Hcl	44	13
Lorazepam	Lorazepam	44	13
Alendronate Sodium	Alendronate Sodium	43	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	15
Jardiance	Empagliflozin	41	12
Fluticasone Propionate	Fluticasone Propionate	40	19
Fenofibrate	Fenofibrate	38	11
Pregabalin	Pregabalin	38	11
Bupropion Xl	Bupropion Hcl	35	11
Janumet Xr	Sitagliptin Phos/Metformin Hcl	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Meloxicam	Meloxicam	31	13
Mirtazapine	Mirtazapine	31	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	11
Chlorthalidone	Chlorthalidone	30	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Diazepam	Diazepam	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Azelastine Hcl	Azelastine Hcl	28	13
Montelukast Sodium	Montelukast Sodium	27	suppressed
Baclofen	Baclofen	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	12
Nifedipine Er	Nifedipine	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Potassium Chloride	Potassium Chloride	22	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	21	suppressed
Varenicline Tartrate	Varenicline Tartrate	21	suppressed
Torsemide	Torsemide	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Ozempic	Semaglutide	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Diclofenac Potassium	Diclofenac Potassium	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Risedronate Sodium	Risedronate Sodium	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Prednisone	Prednisone	16	11
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Estradiol	Estradiol	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Nystatin	Nystatin	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Glipizide	Glipizide	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Halobetasol Propionate	Halobetasol Propionate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error